YU39973B - Process for obtaining n-aryl-n-(4-piperidinyl)-arylacetamides - Google Patents

Process for obtaining n-aryl-n-(4-piperidinyl)-arylacetamides

Info

Publication number
YU39973B
YU39973B YU2336/76A YU233676A YU39973B YU 39973 B YU39973 B YU 39973B YU 2336/76 A YU2336/76 A YU 2336/76A YU 233676 A YU233676 A YU 233676A YU 39973 B YU39973 B YU 39973B
Authority
YU
Yugoslavia
Prior art keywords
arylacetamides
piperidinyl
aryl
obtaining
Prior art date
Application number
YU2336/76A
Other languages
English (en)
Other versions
YU233676A (en
Inventor
S Sanczuk
Fr K H Hermans
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of YU233676A publication Critical patent/YU233676A/xx
Publication of YU39973B publication Critical patent/YU39973B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56Nitrogen atoms
    • C07D211/58Nitrogen atoms attached in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D211/62Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
    • C07D211/66Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4 having a hetero atom as the second substituent in position 4

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
YU2336/76A 1975-09-23 1976-09-22 Process for obtaining n-aryl-n-(4-piperidinyl)-arylacetamides YU39973B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US61513175A 1975-09-23 1975-09-23
US71375676A 1976-08-12 1976-08-12

Publications (2)

Publication Number Publication Date
YU233676A YU233676A (en) 1983-01-21
YU39973B true YU39973B (en) 1985-06-30

Family

ID=27087421

Family Applications (1)

Application Number Title Priority Date Filing Date
YU2336/76A YU39973B (en) 1975-09-23 1976-09-22 Process for obtaining n-aryl-n-(4-piperidinyl)-arylacetamides

Country Status (29)

Country Link
JP (1) JPS6016417B2 (xx)
AT (1) AT363935B (xx)
AU (1) AU510029B2 (xx)
BG (1) BG27543A3 (xx)
CA (1) CA1068271A (xx)
CH (1) CH628623A5 (xx)
CS (1) CS222663B2 (xx)
DE (1) DE2642856A1 (xx)
DK (1) DK150478C (xx)
ES (1) ES451768A1 (xx)
FI (1) FI61482C (xx)
FR (1) FR2325377A1 (xx)
GB (1) GB1539473A (xx)
GR (1) GR58469B (xx)
HU (1) HU172964B (xx)
IE (1) IE43802B1 (xx)
IL (1) IL50522A (xx)
IT (1) IT1073893B (xx)
LU (1) LU75837A1 (xx)
NL (1) NL187267C (xx)
NO (1) NO147672C (xx)
NZ (1) NZ181972A (xx)
PH (1) PH12497A (xx)
PL (2) PL117323B1 (xx)
PT (1) PT65631B (xx)
RO (1) RO70079A (xx)
SE (1) SE427839B (xx)
SU (1) SU747424A3 (xx)
YU (1) YU39973B (xx)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA765684B (en) * 1975-09-23 1978-04-26 Janssen Pharmaceutica Nv Novel n-aryl-n-(1-l-4-piperidinyl)-arylacetamides
JPS62260786A (ja) * 1986-05-08 1987-11-13 株式会社ヘキトク 燻瓦の製造ラインにおける焼成工程後の表面仕上げ装置
JO2769B1 (en) 2005-10-26 2014-03-15 جانسين فارماسوتيكا ان. في Rapid decomposition of physiologically antagonistic agents of the 2-dopamine receptor
JO2642B1 (en) 2006-12-08 2012-06-17 جانسين فارماسوتيكا ان. في Dopamine 2 receptor antagonists are rapidly hydrolyzed
JO2849B1 (en) 2007-02-13 2015-03-15 جانسين فارماسوتيكا ان. في Dopamine 2 receptor antagonists are rapidly hydrolyzed
AU2008240727C1 (en) * 2007-04-23 2013-10-03 Janssen Pharmaceutica N.V. Pyridine derivatives as fast dissociating dopamine 2 receptor antagonists
CN101663292A (zh) 2007-04-23 2010-03-03 詹森药业有限公司 作为快速解离的多巴胺2受体拮抗剂的4-烷氧基哒嗪衍生物
CA2682671C (en) 2007-04-23 2015-11-17 Janssen Pharmaceutica N.V. Thia(dia)zoles as fast dissociating dopamine 2 receptor antagonists
CN102159554B (zh) 2008-07-03 2014-09-24 詹森药业有限公司 作为5-ht6受体拮抗剂的取代的6-(1-哌嗪基)-哒嗪
LT2307374T (lt) 2008-07-31 2017-04-25 Janssen Pharmaceutica Nv Piperazin-1-il-trifluormetil-pakeistieji piridinai kaip greitai disocijuojantys dopamino 2 receptoriaus antagonistai

Also Published As

Publication number Publication date
GR58469B (en) 1977-10-14
FR2325377B1 (xx) 1980-04-18
HU172964B (hu) 1979-01-28
PH12497A (en) 1979-04-05
RO70079A (ro) 1982-10-26
LU75837A1 (xx) 1977-05-04
JPS5239683A (en) 1977-03-28
FI61482C (fi) 1982-08-10
NZ181972A (en) 1978-07-28
CH628623A5 (en) 1982-03-15
AU510029B2 (en) 1980-06-05
DE2642856C2 (xx) 1990-06-21
AU1787876A (en) 1978-03-23
PL192578A1 (pl) 1979-02-26
ES451768A1 (es) 1978-05-01
FI762698A (xx) 1977-03-24
NO763054L (no) 1977-03-24
JPS6016417B2 (ja) 1985-04-25
BG27543A3 (en) 1979-11-12
SU747424A3 (ru) 1980-07-23
CS222663B2 (en) 1983-07-29
NO147672C (no) 1983-05-25
FI61482B (fi) 1982-04-30
PL117323B1 (en) 1981-07-31
IL50522A (en) 1979-09-30
NL187267B (nl) 1991-03-01
IE43802B1 (en) 1981-06-03
SE427839B (sv) 1983-05-09
NL7610513A (nl) 1977-03-25
DK150478C (da) 1987-10-05
YU233676A (en) 1983-01-21
CA1068271A (en) 1979-12-18
IE43802L (en) 1977-03-23
IT1073893B (it) 1985-04-17
GB1539473A (en) 1979-01-31
PT65631A (en) 1976-10-01
ATA702976A (de) 1981-02-15
PT65631B (en) 1978-07-05
SE7610501L (sv) 1977-03-24
DK427876A (da) 1977-03-24
NL187267C (nl) 1991-08-01
DE2642856A1 (de) 1977-03-24
FR2325377A1 (fr) 1977-04-22
DK150478B (da) 1987-03-09
IL50522A0 (en) 1976-11-30
NO147672B (no) 1983-02-14
AT363935B (de) 1981-09-10

Similar Documents

Publication Publication Date Title
YU262076A (en) Process for obtaining 2-phenyl-3-aroylbenzothiophene
HU174396B (hu) Sposob poluchenija 17-al'fa-gidroksi-kortikosteroidov
YU140576A (en) Process for obtaining nifamycin compounds
YU39077A (en) Process for obtaining sulfonyl-benzimidazole compounds
YU248076A (en) Process for obtaining new 1-benzazolylalkyl-4-substituted piperidines
YU100676A (en) Process for obtaining piperazinylpyrazine
YU147976A (en) Process for obtaining 11-deoxy-16-aryloxy-omega-tetranoprostaglandin
GB1548032A (en) Process for preparing amono-acid admides
HU175022B (hu) Sposob poluchenija 11-deoksi-acetilen-aril-prostaglandinov
YU39973B (en) Process for obtaining n-aryl-n-(4-piperidinyl)-arylacetamides
GB1554153A (en) Process for making 2-amino-2-alkylthionitroethylenes
HU174650B (hu) Sposob poluchenija l-piroglutamil-l-prolinamida
YU121176A (en) Process for obtaining rifamcin compounds
YU196776A (en) Process for obtaining phosphor-dichlorido-thiolate
YU45476A (en) Process for obtaining 2-oxo-pyrrolidinyl ecetamide
GB1542488A (en) Process for preparing alpha-amino-gamma-methylmercaptobutyronitrile
YU94182A (en) Process for obtaining 6-alkoxy-alpha-carboxy-penicillin
HU174888B (hu) Sposob poluchenija 1-naftil-n-metil-karbamata
YU262276A (en) Process for obtaining aroyl-phenyl naphthalines
HU175729B (hu) Sposob poluchenija ftoroprostaglandinov
HU174777B (hu) Sposob poluchenija 2-acilamino-oksazolov
HU172553B (hu) Sposob poluchenija proizvodnykh -3-aciloksimetil-cefem- ili -3-tiometil-cefem- soedinenijj
IL50682A0 (en) Process for preparing dihalovinylcyclopropanecarboxylates
HU174633B (hu) Sposob poluchenija glikolal'degida
HU174667B (hu) Sposob poluchenija omega-amino-alkankarbonil-aril-amidov